Bridgefront Capital’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$870K Buy
29,452
+8,158
+38% +$209K 0.23% 138
2026
Q1
$498K Buy
+21,294
New +$385K 0.12% 281
2025
Q1
– Sell
-6,954
Closed -$276K – 594
2024
Q4
$276K Buy
+6,954
New +$314K 0.09% 390
2023
Q2
– Sell
-7,618
Closed -$550K – 429
2023
Q1
$550K Buy
7,618
+1,222
+19% +$95.3K 0.34% 78
2022
Q4
$527K Buy
+6,396
New +$527K 0.37% 86
2021
Q4
– Sell
-4,049
Closed -$258K – 289
2021
Q3
$258K Sell
4,049
-220
-5% -$13.9K 0.27% 174
2021
Q2
$268K Buy
+4,269
New +$268K 0.1% 390

Other funds holding ACHC

Bridgefront Capital's ACHC Position: Q2 2026 in Review

Bridgefront Capital increased its Acadia Healthcare (ACHC) stake by 38% in Q2 2026, buying an estimated $209K and bringing the position to 29,452 shares worth $870K. The position accounts for 0.23% of the portfolio, ranked #138.

Bridgefront Capital first reported a position in ACHC in Q2 2021 and has held it in 7 quarters since. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Bridgefront Capital held 29,452 shares of Acadia Healthcare worth $870K as of Q2 2026.
  • Bridgefront Capital bought 8,158 Acadia Healthcare shares in Q2 2026, an estimated $209K.
  • Acadia Healthcare made up 0.23% of Bridgefront Capital's portfolio in Q2 2026, its #138 holding.
  • Bridgefront Capital first reported a position in Acadia Healthcare in Q2 2021 and has held it in 7 quarters since.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.